MPM BioImpact’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-718,970
| Closed | -$8.47M | – | 45 |
|
|
2024
Q1 | $8.47M | Buy |
718,970
+3,087
| +0.4% | +$36.4K | 1.36% | 29 |
|
|
2023
Q4 | $10.2M | Sell |
715,883
-256
| -0% | -$3.63K | 2.38% | 14 |
|
|
2023
Q3 | $8.71M | Buy |
716,139
+200,000
| +39% | +$2.43M | 2.32% | 17 |
|
|
2023
Q2 | $6.48M | Buy |
516,139
+127,847
| +33% | +$1.61M | 1.31% | 24 |
|
|
2023
Q1 | $4.31M | Sell |
388,292
-12,118
| -3% | -$134K | 1.12% | 24 |
|
|
2022
Q4 | $4.89M | Buy |
400,410
+7,464
| +2% | +$91.1K | 1.27% | 20 |
|
|
2022
Q3 | $4.1M | Sell |
392,946
-102,657
| -21% | -$1.07M | 0.97% | 23 |
|
|
2022
Q2 | $5.32M | Hold |
495,603
| – | – | 1.48% | 21 |
|
|
2022
Q1 | $4.69M | Sell |
495,603
-17,730
| -3% | -$168K | 1.26% | 22 |
|
|
2021
Q4 | $5.93M | Sell |
513,333
-33,225
| -6% | -$384K | 1.08% | 24 |
|
|
2021
Q3 | $5.22M | Buy |
+546,558
| New | +$5.22M | 0.81% | 26 |
|